Sort
8,912 grants matching “sars cov 2”
Implementing Scalable, PAtient-centered Team-based Care for Adults with Type 2 Diabetes and Health Disparities (iPATH)
$781,919Sara Jean Singer · Stanford University · R01 · FY2023 · MD
Implications of long germinal centers (GC) for T and B cell memory and mucosal immunity
$781,696Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2024 · AI
Project 1
$781,556Ali Hassan Ellebedy · Washington University · U19 · FY2025 · AI
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
$781,552Madhav V Dhodapkar · Emory University · U54 · FY2020 · CA
Immune response to COVID-19 vaccine in HIV infected men and women
$781,490Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
COVID-19-related blood-brain barrier and microstructural brain injury; Sex differences and synergy with Alzheimer's disease risk
$781,184Emilie T. Reas · University Of California, San Diego · R01 · FY2024 · AG
Integrated Host/Microbe (IHM) Metagenomics of the Lower Airway to Diagnose PediatricRespiratory Infections, Identify Etiologic Pathogens, and Predict Outcomes
$781,129Charles Langelier · University Of California, San Francisco · R01 · FY2025 · AI
Targeted Gene Delivery Systems Treating Lung Diseases
$781,063Matthew Tirrell · University Of Chicago · R01 · FY2024 · HL
Structural interrogation of vaccine- and infection-induced B cell responses
$780,825Goran Bajic · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · AI
COVID-19 Serosurveys and Vaccine Study Site Preparations
$780,824Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
COVID 19 Respiratory and CNS Pathogenesis in Geriatric Rhesus Monkeys
$780,502Swaminathan Smita Iyer · University Of California At Davis · RF1 · FY2020 · AG
T follicular helper (Tfh) CD4+ T cell, germinal center, and antibody response dysfunction in human recurrent tonsillitis
$780,451Shane P Crotty · La Jolla Institute For Immunology · U19 · FY2021 · AI
Enhanced Detection System for Healthcare-Associated Transmission of Infection
$780,385Lee H. Harrison · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AI
Establishing critical time windows of infant RSV infection in the causal relationship of RSV and childhood asthma
$779,909Pingsheng Wu · Vanderbilt University Medical Center · R01 · FY2024 · HL
Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome
$779,817Yuan Liu · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Unconventional protein secretion-mediated protein quality control in health and diseases
$779,674Yihong Ye · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Advancing the development of a novel class of small molecules for treating pan-coronavirus infections
$779,425Shirit Einav · Stanford University · R01 · FY2021 · AI
Clinical analysis and therapeutic development of exosomal ACE2
$779,400Huiping Liu · Northwestern University At Chicago · R01 · FY2022 · AI
Software for sequencing human antibody proteins from polyclonal immune responses
$779,009Anand Patel · Abterra Biosciences, Inc. · R44 · FY2021 · GM
Michigan Center for Diabetes Translational Research
$779,000Mary Ellen Michele Heisler · University Of Michigan At Ann Arbor · P30 · FY2022 · DK
Michigan Center for Diabetes Translational Research
$779,000Mary Ellen Michele Heisler · University Of Michigan At Ann Arbor · P30 · FY2024 · DK
Michigan Center for Diabetes Translational Research
$779,000Mary Ellen Michele Heisler · University Of Michigan At Ann Arbor · P30 · FY2023 · DK
Blood DNA Methylation Biomarkers of Post Acute Sequelae of SARS CoV 2 Infection (PASC)
$778,634Adolfo Ariel Jaitovich · Albany Medical College · R01 · FY2024 · AI
Surveillance and identification of variants of concern within circulating SARS-CoV-2 across Kentucky
$778,440Jun Yan · University Of Louisville · P20 · FY2021 · GM
Novel diagnostic tools and animal model system for study human/animal interface of COVID-19
$778,213Ying Fang · University Of Illinois At Urbana-Champaign · R01 · FY2022 · AI